To dye or not to dye? That is beyond question! Optimising surveillance colonoscopy is indispensable for detecting dysplasia in ulcerative colitis [7]

Gut

Volumn 53, Issue 11, 2004, Pages 1722-

  Hata, K ^a   Watanabe, T ^a   Shinozaki, M ^a   Kojima, T ^a   Nagawa, H ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET; DYE; METHYLENE BLUE;

COLON BIOPSY; COLON CANCER; COLONOSCOPY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DYSPLASIA; HUMAN; LETTER; MEDICAL DECISION MAKING; PATIENT MONITORING; PRIORITY JOURNAL; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONOSCOPY; COLORING AGENTS; HUMANS; PRECANCEROUS CONDITIONS;

EID: 7244254173     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer 2003;89:1232-6.
2. Hata K, Watanabe T, Motoi T, et al. Pitfalls of pit pattern diagnosis in ulcerative colitis-associated dysplasia. Gastroenterology 2004;126:374-6.
3. Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14.
4. Kiesslich R, Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.